Molecular Genetic Analysis and Prenatal Diagnosis of a Family With MECP2 Duplication Syndrome.
4 affiliations
- 1Department of Laboratory Center, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Zhuang Autonomous Region, China.
- 2Graduate School of Youjiang Medical University for Nationalities, Baise, Guangxi Zhuang Autonomous Region, China.
- 3Key Laboratory of Research on Clinical Molecular Diagnosis for High Incidence Diseases in Western Guangxi of Guangxi Higher Education Institutions, Education Department of Guangxi Zhuang Autonomous Region, Baise, Guangxi Zhuang Autonomous Region, China.
- 4Guangxi Engineering Research Center for Precise Genetic Testing of Long-dwelling Nationalities, Baise, Guangxi Zhuang Autonomous Region, China.
Abstract
Objective
This study aimed to conduct a molecular genetic analysis and prenatal diagnosis for a family with MECP2 duplication syndrome (MDS), with the goal of improving diagnostic accuracy and enabling informed reproductive decisions to reduce the incidence of this condition.Methods
The study involved a proband (a 15-week-old fetus), his symptomatic older brother, and their parents. Genomic DNA from chorionic villus and peripheral blood samples was analyzed using high-throughput sequencing to detect chromosomal copy number variations (CNVs). To confirm the findings, multiplex ligation-dependent probe amplification (MLPA) was specifically employed.Results
High-throughput sequencing identified a 0.35 Mb duplication at Xq28 in the fetus and his mother, and a 0.4 Mb duplication in the brother. The duplicated region contained the critical MECP2 gene. MLPA analysis confirmed the MECP2 gene duplication in the fetus, leading to a definitive diagnosis of MDS. The mother was identified as an asymptomatic carrier.Conclusion
Both the proband and his brother were diagnosed with MDS, having inherited the duplication from their asymptomatic mother. The combined use of high-throughput sequencing and MLPA proved to be an effective strategy for accurate pedigree analysis and prenatal diagnosis of MDS, providing a crucial basis for genetic counseling.
Related
- Newborn Screening of Primary Carnitine Deficiency and Prenatal Genetic Diagnosis for a Recurrence‐Risk Family
- Fraser Syndrome From Prenatal Diagnosis to Multidisciplinary Management and Long-Term Care: A Narrative Review.
- Prenatal diagnosis of Fowler syndrome with two novel pathogenic variants of FLVCR2
- Long-Term Experience in the Molecular Genetic Diagnosis of Friedreich Ataxia in the Russian Federation
- Functional Validation of a CC2D2A Non-Canonical Splice-Site Variant Supports Prenatal Molecular Testing in Joubert Syndrome.
BibTeX
@article{lin2026molecular,
title = {{Molecular Genetic Analysis and Prenatal Diagnosis of a Family With MECP2 Duplication Syndrome.}},
author = {FengQiu Lin and DingGuo Chen and ZhengLin Lu and Yu Huang and ChunFang Wang and JuHua Liang and XueJuan Nong and ZhengYi Chang and FuBo Wei and GuiDan Xu},
journal = {Journal of clinical laboratory analysis},
year = {2026},
month = oct,
doi = {10.1002/jcla.70373},
url = {https://europepmc.org/article/MED/42885210},
note = {CC BY},
}
RIS
TY - JOUR
TI - Molecular Genetic Analysis and Prenatal Diagnosis of a Family With MECP2 Duplication Syndrome.
AU - FengQiu Lin
AU - DingGuo Chen
AU - ZhengLin Lu
AU - Yu Huang
AU - ChunFang Wang
AU - JuHua Liang
AU - XueJuan Nong
AU - ZhengYi Chang
AU - FuBo Wei
AU - GuiDan Xu
PY - 2026
DA - 2026/10/15
JO - Journal of clinical laboratory analysis
DO - 10.1002/jcla.70373
UR - https://europepmc.org/article/MED/42885210
AB - Objective This study aimed to conduct a molecular genetic analysis and prenatal diagnosis for a family with MECP2 duplication syndrome (MDS), with the goal of improving diagnostic accuracy and enabling informed reproductive decisions to reduce the incidence of this condition.Methods The study involved a proband (a 15-week-old fetus), his symptomatic older brother, and their parents. Genomic DNA from chorionic villus and peripheral blood samples was analyzed using high-throughput sequencing to detect chromosomal copy number variations (CNVs). To confirm the findings, multiplex ligation-dependent probe amplification (MLPA) was specifically employed.Results High-throughput sequencing identified a 0.35 Mb duplication at Xq28 in the fetus and his mother, and a 0.4 Mb duplication in the brother. The duplicated region contained the critical MECP2 gene. MLPA analysis confirmed the MECP2 gene duplication in the fetus, leading to a definitive diagnosis of MDS. The mother was identified as an asymptomatic carrier.Conclusion Both the proband and his brother were diagnosed with MDS, having inherited the duplication from their asymptomatic mother. The combined use of high-throughput sequencing and MLPA proved to be an effective strategy for accurate pedigree analysis and prenatal diagnosis of MDS, providing a crucial basis for genetic counseling.
SN - 0887-8013
SN - 1098-2825
ER -